+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Third-party Medical Testing Services Market - Global Forecast 2026-2032- Product Image
Third-party Medical Testing Services Market - Global Forecast 2026-2032- Product Image
Sale

Third-party Medical Testing Services Market - Global Forecast 2026-2032

  • Report

  • 197 Pages
  • September 2026
  • Region: Global
  • 360iResearch™
  • ID: 6080033
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Third-party Medical Testing Services Market is projected to reach USD 4.30 Billion in 2026. It is expected to continue growing at a CAGR of 10.31%, reaching USD 7.84 Billion by 2032.

Third-Party Medical Testing Services: Executive Overview

Third-party medical testing services encompass independent laboratory, diagnostic, screening, and related analytical activities performed for healthcare providers, employers, research organizations, public agencies, and other customers. The sector supports clinical decision-making, disease surveillance, preventive care, clinical research, and quality assurance. Its development is shaped by demand for accurate and timely results, regulatory compliance, specialized testing capacity, and interoperable reporting.

How Regulation, Specialization, and Access Are Reshaping Testing

The landscape is shifting toward more specialized assays, stronger quality controls, digital result delivery, and closer integration with clinical workflows. Providers and purchasers increasingly emphasize analytical validity, turnaround time, specimen integrity, data protection, accreditation, and transparent governance. Decentralized collection, home-based sampling, molecular methods, automation, and multiplex approaches are expanding the range of services, while reimbursement scrutiny and workforce constraints increase pressure to demonstrate clinical utility and operational efficiency.

Artificial Intelligence Is Strengthening Interpretation and Operations

Artificial intelligence is being applied to laboratory workflow management, image and signal interpretation, quality-control monitoring, test utilization review, result prioritization, and demand planning. Its practical contribution depends on representative training data, independent validation, explainability, cybersecurity, and human oversight. AI can help identify anomalies and reduce administrative burden, but it does not remove the need for qualified professionals, established reference ranges, confirmatory testing, or compliance with medical-device and privacy requirements.

Regional Insights Across Global Testing Systems

North America is characterized by advanced laboratory infrastructure, broad use of specialized diagnostics, and strong attention to accreditation, privacy, and reimbursement discipline. Europe combines mature healthcare systems with stringent data and quality requirements, while the European market also reflects differences in procurement and national coverage. Asia-Pacific includes highly developed testing ecosystems alongside rapidly expanding access needs, creating demand for scalable infrastructure and workforce development. Latin America is balancing concentration in major urban centers with efforts to improve regional access and referral networks. The Middle East is investing in healthcare capacity and specialized services, while Africa continues to prioritize dependable basic diagnostics, disease surveillance, supply-chain resilience, and equitable geographic coverage.

Group-Level Priorities Across ASEAN, BRICS, EU, G7, GCC, and NATO

ASEAN members face varied regulatory systems and healthcare capacity, making interoperability, cross-border referral pathways, and standardized quality practices important. BRICS economies span substantial differences in infrastructure and access, with shared interest in domestic capability, public-health resilience, and technology transfer. The European Union emphasizes harmonized quality, privacy, and cross-border health-data principles. G7 systems generally focus on advanced diagnostics, resilient supply chains, research governance, and responsible innovation. GCC countries are strengthening centralized healthcare infrastructure and specialized testing capacity, while NATO members place additional emphasis on preparedness, continuity of medical support, biosafety, and secure information exchange.

Country-Level Signals for Service Providers and Purchasers

Australia emphasizes quality-assured diagnostics across dispersed populations. Brazil is addressing geographic inequality and the integration of private and public testing networks. Canada combines sophisticated laboratory services with access challenges across remote and northern communities. China is expanding advanced diagnostic capability while reinforcing regulatory oversight and domestic resilience. France, Germany, Italy, and Spain operate within established European quality and privacy frameworks, with differing procurement and health-system structures. India is balancing rapid diagnostic expansion with accreditation, affordability, and uneven regional capacity. Japan and South Korea emphasize automation, precision, and high reliability. Mexico is developing broader access and referral capacity. Russia’s system reflects the importance of domestic supply, centralized coordination, and continuity. The United Kingdom focuses on system integration, validation, and public-sector capacity. The United States combines extensive specialized testing with intense attention to compliance, utilization management, cybersecurity, and reimbursement.

Priorities for Leaders Building Reliable Testing Networks

Industry leaders should organize portfolios around clinically meaningful use cases, validated performance, and clear customer workflows rather than novelty alone. They should invest in interoperable information systems, resilient specimen logistics, accreditation, cybersecurity, and workforce training; establish governance for AI and other advanced analytics; and use risk-based quality management across collection, transport, analysis, reporting, and data retention. Partnerships with health systems, public agencies, research organizations, and local providers can improve access, while transparent reporting of limitations and turnaround performance strengthens trust.

Methodology for a Data-Grounded Executive Summary

This summary uses the defined market scope of third-party medical testing services and organizes interpretation around service characteristics, healthcare delivery needs, regulation, technology, infrastructure, and geography. Regional, group, and country observations are synthesized qualitatively from established structural factors such as health-system maturity, diagnostic access, regulatory expectations, public-health priorities, digital readiness, and supply-chain conditions. No market estimates, shares, forecasts, or company-specific claims are used.

Conclusion: Quality, Integration, and Equity Define Competitive Readiness

Third-party medical testing services are becoming more specialized, digitally connected, and operationally integrated with healthcare and research. Sustainable progress will depend on dependable quality systems, responsible adoption of AI, secure data exchange, resilient logistics, and service models that extend accurate testing beyond major centers. Leaders that align innovation with validation, regulation, workforce capability, and patient access will be best positioned to support trusted clinical and public-health outcomes.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. New Revenue Opportunities
3.4. Next-Generation Business Models
3.5. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Third-party Medical Testing Services Market, by Test Type
7.1. Introduction
7.2. Clinical Chemistry
7.2.1. Automated Chemistry Analyzers
7.2.2. Point Of Care Chemistry Testing
7.3. Hematology
7.4. Histopathology
7.5. Immunology
7.6. Microbiology
7.7. Molecular Diagnostics
7.7.1. Next Generation Sequencing
7.7.2. PCR
8. Third-party Medical Testing Services Market, by Technology
8.1. Introduction
8.2. Immunoassays
8.3. Mass Spectrometry
8.4. Microscopy
8.5. PCR
8.5.1. Digital PCR
8.5.2. Quantitative PCR
8.6. Sequencing
9. Third-party Medical Testing Services Market, by Sample Type
9.1. Introduction
9.2. Blood
9.2.1. Plasma
9.2.2. Serum
9.2.3. Whole Blood
9.3. Saliva
9.4. Tissue
9.5. Urine
10. Third-party Medical Testing Services Market, by End User
10.1. Introduction
10.2. Academic And Research Institutes
10.3. Diagnostic Centers
10.4. Hospitals
10.4.1. Private Hospitals
10.4.2. Public Hospitals
10.5. Pharmaceutical And Biotech Companies
11. Third-party Medical Testing Services Market, by Application
11.1. Introduction
11.2. Cardiology
11.3. Genetic Testing
11.4. Infectious Diseases
11.5. Neurology
11.6. Oncology
11.6.1. Liquid Biopsy
11.6.2. Tissue Biopsy
12. Third-party Medical Testing Services Market, by Region
12.1. Introduction
12.2. Asia-Pacific
12.3. North America
12.4. Latin America
12.5. Europe
12.6. Middle East
12.7. Africa
13. Third-party Medical Testing Services Market, by Group
13.1. Introduction
13.2. ASEAN
13.3. GCC
13.4. European Union
13.5. BRICS
13.6. G7
13.7. NATO
14. Third-party Medical Testing Services Market, by Country
14.1. Introduction
14.2. United States
14.3. Canada
14.4. Mexico
14.5. Brazil
14.6. United Kingdom
14.7. Germany
14.8. France
14.9. Russia
14.10. Italy
14.11. Spain
14.12. China
14.13. India
14.14. Japan
14.15. Australia
14.16. South Korea
15. Competitive Landscape
15.1. Market Share Analysis, 2025
15.2. Market Concentration Analysis, 2025
15.2.1. Concentration Ratio (CR)
15.2.2. Herfindahl Hirschman Index (HHI)
15.3. Recent Developments & Impact Analysis, 2025
15.4. Product Portfolio Analysis, 2025
15.5. Benchmarking Analysis, 2025
16. Company Profiles
16.1. ARUP Laboratories LLC
16.2. Bio-Reference Laboratories Inc
16.3. Cerba Healthcare SA
16.4. Cerberus Diagnostics Inc
16.5. Charles River Laboratories International Inc
16.6. Element Materials Technology Ltd
16.7. Eurofins Scientific SE
16.8. Fulgent Genetics Inc
16.9. ICON plc
16.10. Intertek Group plc
16.11. IQVIA Holdings Inc
16.12. Labcorp Holdings Inc
16.13. Mayo Foundation for Medical Education and Research
16.14. Medpace Holdings Inc
16.15. NeoGenomics Laboratories Inc
16.16. OPKO Health Inc
16.17. PPD Inc
16.18. Quest Diagnostics Incorporated
16.19. SGS SA
16.20. Sonic Healthcare Limited
16.21. SYNLAB AG
16.22. TÜV SÜD AG
16.23. Unilabs Holding SA
16.24. WuXi AppTec Co Ltd
17. Key Experts
LIST OF FIGURES
FIGURE 1. Global Third-party Medical Testing Services Market, Years Considered for the Study
FIGURE 2. Global Third-party Medical Testing Services Market, Research Design
FIGURE 3. Global Third-party Medical Testing Services Market, Research Framework
FIGURE 4. Global Third-party Medical Testing Services Market, Data Triangulation
FIGURE 5. Global Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
FIGURE 6. Global Third-party Medical Testing Services Market Size, by Test Type, 2025 vs 2032 (%)
FIGURE 7. Global Third-party Medical Testing Services Market Size, by Test Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 8. Global Third-party Medical Testing Services Market Size, by Technology, 2025 vs 2032 (%)
FIGURE 9. Global Third-party Medical Testing Services Market Size, by Technology, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 10. Global Third-party Medical Testing Services Market Size, by Sample Type, 2025 vs 2032 (%)
FIGURE 11. Global Third-party Medical Testing Services Market Size, by Sample Type, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 12. Global Third-party Medical Testing Services Market Size, by End User, 2025 vs 2032 (%)
FIGURE 13. Global Third-party Medical Testing Services Market Size, by End User, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 14. Global Third-party Medical Testing Services Market Size, by Application, 2025 vs 2032 (%)
FIGURE 15. Global Third-party Medical Testing Services Market Size, by Application, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 16. Global Third-party Medical Testing Services Market Size, by Region, 2025 vs 2032 (%)
FIGURE 17. Global Third-party Medical Testing Services Market Size, by Region, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 18. Global Third-party Medical Testing Services Market Size, by Group, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 19. Global Third-party Medical Testing Services Market Size, by Country, 2025 vs 2032 (%)
FIGURE 20. Global Third-party Medical Testing Services Market Size, by Country, 2025 vs 2026 vs 2032 (USD Million)
FIGURE 21. Global Third-party Medical Testing Services Market Share, by Key Player, 2025
LIST OF TABLES
TABLE 1. Global Third-party Medical Testing Services Market Segmentation & Coverage
TABLE 2. Global Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 3. Global Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 4. Global Clinical Chemistry Market Size, by Region, 2017-2032 (USD Million)
TABLE 5. Global Clinical Chemistry Market Size, by Group, 2017-2032 (USD Million)
TABLE 6. Global Clinical Chemistry Market Size, by Country, 2017-2032 (USD Million)
TABLE 7. Global Automated Chemistry Analyzers Market Size, by Region, 2017-2032 (USD Million)
TABLE 8. Global Automated Chemistry Analyzers Market Size, by Group, 2017-2032 (USD Million)
TABLE 9. Global Automated Chemistry Analyzers Market Size, by Country, 2017-2032 (USD Million)
TABLE 10. Global Point Of Care Chemistry Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 11. Global Point Of Care Chemistry Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 12. Global Point Of Care Chemistry Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 13. Global Hematology Market Size, by Region, 2017-2032 (USD Million)
TABLE 14. Global Hematology Market Size, by Group, 2017-2032 (USD Million)
TABLE 15. Global Hematology Market Size, by Country, 2017-2032 (USD Million)
TABLE 16. Global Histopathology Market Size, by Region, 2017-2032 (USD Million)
TABLE 17. Global Histopathology Market Size, by Group, 2017-2032 (USD Million)
TABLE 18. Global Histopathology Market Size, by Country, 2017-2032 (USD Million)
TABLE 19. Global Immunology Market Size, by Region, 2017-2032 (USD Million)
TABLE 20. Global Immunology Market Size, by Group, 2017-2032 (USD Million)
TABLE 21. Global Immunology Market Size, by Country, 2017-2032 (USD Million)
TABLE 22. Global Microbiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 23. Global Microbiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 24. Global Microbiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 25. Global Molecular Diagnostics Market Size, by Region, 2017-2032 (USD Million)
TABLE 26. Global Molecular Diagnostics Market Size, by Group, 2017-2032 (USD Million)
TABLE 27. Global Molecular Diagnostics Market Size, by Country, 2017-2032 (USD Million)
TABLE 28. Global Next Generation Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 29. Global Next Generation Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 30. Global Next Generation Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 31. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 32. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 33. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 34. Global Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 35. Global Immunoassays Market Size, by Region, 2017-2032 (USD Million)
TABLE 36. Global Immunoassays Market Size, by Group, 2017-2032 (USD Million)
TABLE 37. Global Immunoassays Market Size, by Country, 2017-2032 (USD Million)
TABLE 38. Global Mass Spectrometry Market Size, by Region, 2017-2032 (USD Million)
TABLE 39. Global Mass Spectrometry Market Size, by Group, 2017-2032 (USD Million)
TABLE 40. Global Mass Spectrometry Market Size, by Country, 2017-2032 (USD Million)
TABLE 41. Global Microscopy Market Size, by Region, 2017-2032 (USD Million)
TABLE 42. Global Microscopy Market Size, by Group, 2017-2032 (USD Million)
TABLE 43. Global Microscopy Market Size, by Country, 2017-2032 (USD Million)
TABLE 44. Global PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 45. Global PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 46. Global PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 47. Global Digital PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 48. Global Digital PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 49. Global Digital PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 50. Global Quantitative PCR Market Size, by Region, 2017-2032 (USD Million)
TABLE 51. Global Quantitative PCR Market Size, by Group, 2017-2032 (USD Million)
TABLE 52. Global Quantitative PCR Market Size, by Country, 2017-2032 (USD Million)
TABLE 53. Global Sequencing Market Size, by Region, 2017-2032 (USD Million)
TABLE 54. Global Sequencing Market Size, by Group, 2017-2032 (USD Million)
TABLE 55. Global Sequencing Market Size, by Country, 2017-2032 (USD Million)
TABLE 56. Global Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 57. Global Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 58. Global Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 59. Global Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 60. Global Plasma Market Size, by Region, 2017-2032 (USD Million)
TABLE 61. Global Plasma Market Size, by Group, 2017-2032 (USD Million)
TABLE 62. Global Plasma Market Size, by Country, 2017-2032 (USD Million)
TABLE 63. Global Serum Market Size, by Region, 2017-2032 (USD Million)
TABLE 64. Global Serum Market Size, by Group, 2017-2032 (USD Million)
TABLE 65. Global Serum Market Size, by Country, 2017-2032 (USD Million)
TABLE 66. Global Whole Blood Market Size, by Region, 2017-2032 (USD Million)
TABLE 67. Global Whole Blood Market Size, by Group, 2017-2032 (USD Million)
TABLE 68. Global Whole Blood Market Size, by Country, 2017-2032 (USD Million)
TABLE 69. Global Saliva Market Size, by Region, 2017-2032 (USD Million)
TABLE 70. Global Saliva Market Size, by Group, 2017-2032 (USD Million)
TABLE 71. Global Saliva Market Size, by Country, 2017-2032 (USD Million)
TABLE 72. Global Tissue Market Size, by Region, 2017-2032 (USD Million)
TABLE 73. Global Tissue Market Size, by Group, 2017-2032 (USD Million)
TABLE 74. Global Tissue Market Size, by Country, 2017-2032 (USD Million)
TABLE 75. Global Urine Market Size, by Region, 2017-2032 (USD Million)
TABLE 76. Global Urine Market Size, by Group, 2017-2032 (USD Million)
TABLE 77. Global Urine Market Size, by Country, 2017-2032 (USD Million)
TABLE 78. Global Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 79. Global Academic And Research Institutes Market Size, by Region, 2017-2032 (USD Million)
TABLE 80. Global Academic And Research Institutes Market Size, by Group, 2017-2032 (USD Million)
TABLE 81. Global Academic And Research Institutes Market Size, by Country, 2017-2032 (USD Million)
TABLE 82. Global Diagnostic Centers Market Size, by Region, 2017-2032 (USD Million)
TABLE 83. Global Diagnostic Centers Market Size, by Group, 2017-2032 (USD Million)
TABLE 84. Global Diagnostic Centers Market Size, by Country, 2017-2032 (USD Million)
TABLE 85. Global Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 86. Global Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 87. Global Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 88. Global Private Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 89. Global Private Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 90. Global Private Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 91. Global Public Hospitals Market Size, by Region, 2017-2032 (USD Million)
TABLE 92. Global Public Hospitals Market Size, by Group, 2017-2032 (USD Million)
TABLE 93. Global Public Hospitals Market Size, by Country, 2017-2032 (USD Million)
TABLE 94. Global Pharmaceutical And Biotech Companies Market Size, by Region, 2017-2032 (USD Million)
TABLE 95. Global Pharmaceutical And Biotech Companies Market Size, by Group, 2017-2032 (USD Million)
TABLE 96. Global Pharmaceutical And Biotech Companies Market Size, by Country, 2017-2032 (USD Million)
TABLE 97. Global Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 98. Global Cardiology Market Size, by Region, 2017-2032 (USD Million)
TABLE 99. Global Cardiology Market Size, by Group, 2017-2032 (USD Million)
TABLE 100. Global Cardiology Market Size, by Country, 2017-2032 (USD Million)
TABLE 101. Global Genetic Testing Market Size, by Region, 2017-2032 (USD Million)
TABLE 102. Global Genetic Testing Market Size, by Group, 2017-2032 (USD Million)
TABLE 103. Global Genetic Testing Market Size, by Country, 2017-2032 (USD Million)
TABLE 104. Global Infectious Diseases Market Size, by Region, 2017-2032 (USD Million)
TABLE 105. Global Infectious Diseases Market Size, by Group, 2017-2032 (USD Million)
TABLE 106. Global Infectious Diseases Market Size, by Country, 2017-2032 (USD Million)
TABLE 107. Global Neurology Market Size, by Region, 2017-2032 (USD Million)
TABLE 108. Global Neurology Market Size, by Group, 2017-2032 (USD Million)
TABLE 109. Global Neurology Market Size, by Country, 2017-2032 (USD Million)
TABLE 110. Global Oncology Market Size, by Region, 2017-2032 (USD Million)
TABLE 111. Global Oncology Market Size, by Group, 2017-2032 (USD Million)
TABLE 112. Global Oncology Market Size, by Country, 2017-2032 (USD Million)
TABLE 113. Global Liquid Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 114. Global Liquid Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 115. Global Liquid Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 116. Global Tissue Biopsy Market Size, by Region, 2017-2032 (USD Million)
TABLE 117. Global Tissue Biopsy Market Size, by Group, 2017-2032 (USD Million)
TABLE 118. Global Tissue Biopsy Market Size, by Country, 2017-2032 (USD Million)
TABLE 119. Global Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 120. Asia-Pacific Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 121. Asia-Pacific Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 122. Asia-Pacific Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 123. Asia-Pacific Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 124. Asia-Pacific Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 125. Asia-Pacific Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 126. Asia-Pacific Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 127. Asia-Pacific Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 128. Asia-Pacific Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 129. Asia-Pacific Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 130. Asia-Pacific Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 131. Asia-Pacific Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 132. North America Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 133. North America Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 134. North America Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 135. North America Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 136. North America Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 137. North America Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 138. North America Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 139. North America Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 140. North America Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 141. North America Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 142. North America Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 143. North America Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 144. Latin America Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 145. Latin America Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 146. Latin America Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 147. Latin America Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 148. Latin America Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 149. Latin America Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 150. Latin America Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 151. Latin America Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 152. Latin America Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 153. Latin America Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 154. Latin America Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 155. Latin America Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 156. Europe Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 157. Europe Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 158. Europe Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 159. Europe Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 160. Europe Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 161. Europe Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 162. Europe Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 163. Europe Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 164. Europe Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 165. Europe Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 166. Europe Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 167. Europe Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 168. Middle East Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 169. Middle East Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 170. Middle East Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 171. Middle East Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 172. Middle East Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 173. Middle East Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 174. Middle East Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 175. Middle East Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 176. Middle East Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 177. Middle East Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 178. Middle East Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 179. Middle East Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 180. Africa Third-party Medical Testing Services Market Size, by Region, 2017-2032 (USD Million)
TABLE 181. Africa Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 182. Africa Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 183. Africa Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 184. Africa Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 185. Africa Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 186. Africa Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 187. Africa Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 188. Africa Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 189. Africa Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 190. Africa Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 191. Africa Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 192. Global Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 193. ASEAN Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 194. ASEAN Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 195. ASEAN Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 196. ASEAN Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 197. ASEAN Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 198. ASEAN Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 199. ASEAN Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 200. ASEAN Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 201. ASEAN Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 202. ASEAN Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 203. ASEAN Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 204. ASEAN Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 205. GCC Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 206. GCC Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 207. GCC Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 208. GCC Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 209. GCC Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 210. GCC Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 211. GCC Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 212. GCC Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 213. GCC Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 214. GCC Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 215. GCC Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 216. GCC Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 217. European Union Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 218. European Union Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 219. European Union Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 220. European Union Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 221. European Union Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 222. European Union Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 223. European Union Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 224. European Union Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 225. European Union Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 226. European Union Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 227. European Union Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 228. European Union Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 229. BRICS Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 230. BRICS Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 231. BRICS Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 232. BRICS Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 233. BRICS Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 234. BRICS Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 235. BRICS Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 236. BRICS Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 237. BRICS Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 238. BRICS Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 239. BRICS Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 240. BRICS Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 241. G7 Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 242. G7 Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 243. G7 Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 244. G7 Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 245. G7 Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 246. G7 Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 247. G7 Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 248. G7 Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 249. G7 Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 250. G7 Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 251. G7 Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 252. G7 Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 253. NATO Third-party Medical Testing Services Market Size, by Group, 2017-2032 (USD Million)
TABLE 254. NATO Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 255. NATO Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 256. NATO Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 257. NATO Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 258. NATO Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 259. NATO Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 260. NATO Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 261. NATO Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 262. NATO Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 263. NATO Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 264. NATO Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 265. Global Third-party Medical Testing Services Market Size, by Country, 2017-2032 (USD Million)
TABLE 266. United States Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 267. United States Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 268. United States Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 269. United States Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 270. United States Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 271. United States Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 272. United States Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 273. United States Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 274. United States Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 275. United States Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 276. United States Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 277. United States Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 278. Canada Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 279. Canada Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 280. Canada Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 281. Canada Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 282. Canada Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 283. Canada Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 284. Canada Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 285. Canada Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 286. Canada Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 287. Canada Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 288. Canada Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 289. Canada Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 290. Mexico Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 291. Mexico Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 292. Mexico Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 293. Mexico Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 294. Mexico Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 295. Mexico Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 296. Mexico Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 297. Mexico Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 298. Mexico Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 299. Mexico Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 300. Mexico Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 301. Mexico Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 302. Brazil Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 303. Brazil Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 304. Brazil Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 305. Brazil Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 306. Brazil Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 307. Brazil Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 308. Brazil Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 309. Brazil Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 310. Brazil Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 311. Brazil Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 312. Brazil Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 313. Brazil Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 314. United Kingdom Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 315. United Kingdom Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 316. United Kingdom Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 317. United Kingdom Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 318. United Kingdom Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 319. United Kingdom Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 320. United Kingdom Third-party Medical Testing Services Market Size, by Sample Type, 2017-2032 (USD Million)
TABLE 321. United Kingdom Third-party Medical Testing Services Market Size, by Blood, 2017-2032 (USD Million)
TABLE 322. United Kingdom Third-party Medical Testing Services Market Size, by End User, 2017-2032 (USD Million)
TABLE 323. United Kingdom Third-party Medical Testing Services Market Size, by Hospitals, 2017-2032 (USD Million)
TABLE 324. United Kingdom Third-party Medical Testing Services Market Size, by Application, 2017-2032 (USD Million)
TABLE 325. United Kingdom Third-party Medical Testing Services Market Size, by Oncology, 2017-2032 (USD Million)
TABLE 326. Germany Third-party Medical Testing Services Market Size, 2017-2032 (USD Million)
TABLE 327. Germany Third-party Medical Testing Services Market Size, by Test Type, 2017-2032 (USD Million)
TABLE 328. Germany Third-party Medical Testing Services Market Size, by Clinical Chemistry, 2017-2032 (USD Million)
TABLE 329. Germany Third-party Medical Testing Services Market Size, by Molecular Diagnostics, 2017-2032 (USD Million)
TABLE 330. Germany Third-party Medical Testing Services Market Size, by Technology, 2017-2032 (USD Million)
TABLE 331. Germany Third-party Medical Testing Services Market Size, by PCR, 2017-2032 (USD Million)
TABLE 332. Germany Third-party Medical Te

Companies Mentioned

  • ARUP Laboratories LLC
  • Bio‑Reference Laboratories Inc
  • Cerba Healthcare SA
  • Cerberus Diagnostics Inc
  • Charles River Laboratories International Inc
  • Element Materials Technology Ltd
  • Eurofins Scientific SE
  • Fulgent Genetics Inc
  • ICON plc
  • Intertek Group plc
  • IQVIA Holdings Inc
  • Labcorp Holdings Inc
  • Mayo Foundation for Medical Education and Research
  • Medpace Holdings Inc
  • NeoGenomics Laboratories Inc
  • OPKO Health Inc
  • PPD Inc
  • Quest Diagnostics Incorporated
  • SGS SA
  • Sonic Healthcare Limited
  • SYNLAB AG
  • TÜV SÜD AG
  • Unilabs Holding SA
  • WuXi AppTec Co Ltd

Related Topics

Related Reports

Routine Health Screening Market Report 2026 - Product Image

Routine Health Screening Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Cellular Health Testing - Global Strategic Business Report - Product Image

Cellular Health Testing - Global Strategic Business Report

  • Report
  • 184 Pages
  • Global
From
Sexual Health Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, Sample Type, End User, Age Group - Product Image

Sexual Health Testing Market Outlook 2026-2034: Market Share, and Growth Analysis by Test Type, Sample Type, End User, Age Group

  • Report
  • 160 Pages
  • Global
From
Clinical Diagnostics Market - Global Forecast 2026-2032 - Product Image

Clinical Diagnostics Market - Global Forecast 2026-2032

  • Report
  • 182 Pages
  • Global
From
Monkeypox Virus Antigen Detection Kit Market - Global Forecast 2026-2032 - Product Image

Monkeypox Virus Antigen Detection Kit Market - Global Forecast 2026-2032

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.